What is Sofwave? Complete Guide in Gangnam 2026

Sofwave is an FDA-cleared ultrasound device using SUPERB technology to deliver parallel beam energy at 1.5mm depth across 3 focal zones simultaneously. A single 30-45 minute session of 100-200 shots heats mid-dermal collagen to 60-70 degrees Celsius, triggering neocollagenesis that lifts eyebrows, tightens submental tissue, and reduces fine wrinkles over 8-12 weeks.
What is Sofwave? Complete Guide in Gangnam 2026

How Sofwave Technology Works

Sofwave employs Synchronous Ultrasound Parallel Beam Technology, branded as SUPERB, to deliver focused ultrasound energy to the mid-dermis at a precise depth of 1.5mm. Unlike traditional focused ultrasound systems that fire a single beam at one focal point, Sofwave generates 7 parallel beams that create 3 thermal zones simultaneously. This multi-focal approach heats a larger volume of dermal tissue per pulse, enabling comprehensive treatment in fewer passes.

The device raises mid-dermal temperature to 60-70 degrees Celsius, which denatures existing collagen fibers and initiates a controlled wound-healing response. An integrated Sofcool cooling system maintains the epidermal surface at a safe temperature throughout treatment, reducing discomfort and eliminating the risk of surface burns. The thermal effect triggers fibroblast activation and neocollagenesis that continues for 12-16 weeks after treatment.

What Sofwave Treats

Primary Indications

Sofwave received FDA 510(k) clearance in 2019 for lifting the eyebrow and submental tissue, as well as improving facial lines and wrinkles. Clinical trials demonstrate a 95% patient satisfaction rate, with measurable tissue tightening documented via standardized photography at 12-week follow-up. The device effectively addresses mild to moderate skin laxity of the lower face, jawline, and neck without incisions or injectable agents.

Treatment Areas

The Sofwave applicator treats the full face including forehead, periorbital region, cheeks, nasolabial folds, jawline, and submental zone. Neck treatment addresses horizontal lines and vertical bands. Each anatomical zone requires 15-25 shots, and a full-face protocol typically involves 100-200 shots delivered over 30-45 minutes. Practitioners adjust energy levels between 0.7-2.0 joules per treatment line based on tissue thickness and patient tolerance.

Who Benefits from Sofwave Treatment

Ideal candidates are adults aged 30-60 with mild to moderate facial laxity classified as grade 1-2 on the Merz Aesthetics Scale. Patients seeking preventive anti-aging treatment in their early 30s also benefit, as stimulating collagen production before significant degradation occurs maintains skin structure longer. Sofwave suits individuals who want lifting results without the 4-6 week recovery period associated with surgical facelifts.

Contraindications include active skin infections at the treatment site, open wounds, severe cystic acne, and pregnancy. Patients with metal implants in the facial region should disclose this during consultation. Those with severe grade 3-4 sagging typically require surgical intervention, as energy-based devices cannot replicate the tissue repositioning achieved through surgical excision and suturing.

Sofwave Treatment Experience and Recovery

A Sofwave session begins with cleansing and application of ultrasound gel. No topical anesthesia is required for most patients, though it may be applied 20-30 minutes before treatment upon request. Patients report a warm, pulsing sensation rated 2-4 on a 10-point pain scale, significantly lower than the 5-7 rating typical of focused ultrasound at deeper depths. The session lasts 30-45 minutes for a full face protocol.

Post-treatment, patients experience mild redness lasting 30-60 minutes. There is zero downtime: normal activities including exercise resume the same day. No bruising, swelling, or tenderness occurs in most cases. Initial skin tightening becomes visible at 4 weeks, with progressive improvement continuing through 12 weeks as new collagen matures and reorganizes within the dermal matrix.

Expected Results and Maintenance

Published data shows that 90% of patients demonstrate measurable improvement in skin laxity at the 12-week mark. Sofwave targets the mid-dermis specifically, complementing deeper treatments that address the SMAS layer. Results from a single session last 6-12 months depending on the patient's age, skin quality, and collagen turnover rate. Kerscher M et al. J Drugs Dermatol. 2021;20(6):s54-s58. doi:10.36849/jdd.6073

Maintenance protocols involve 1 session every 6-12 months. RE:BERRY Gangnam offers Sofwave as both a standalone treatment and as part of multi-layer lifting protocols that combine mid-dermal and deep tissue stimulation. Patients who maintain consistent annual sessions report cumulative improvement, as each treatment reinforces residual collagen from prior sessions while generating additional new fibers.

Frequently Asked Questions

What does Sofwave treat?
Sofwave targets 5 key areas: eyebrow lifting, jawline tightening, submental firming, neck line reduction, and facial wrinkle improvement. The SUPERB technology delivers parallel ultrasound beams at 1.5mm depth to heat mid-dermal collagen to 60-70 degrees Celsius, triggering neocollagenesis that produces visible tightening over 8-12 weeks without incisions or injectable agents.
Who is a good candidate for Sofwave?
Adults aged 30-60 with Merz scale grade 1-2 facial laxity are optimal candidates, representing approximately 65% of patients seeking non-surgical lifting. Early jowling, mild neck sagging, and fine wrinkles respond best. Contraindications include pregnancy, active skin infections, open wounds, and severe grade 3-4 sagging that requires surgical correction.
How long does Sofwave take?
A full-face Sofwave session requires 30-45 minutes for 100-200 shots, with each anatomical zone taking 15-25 shots. No pre-treatment numbing is needed for most patients, eliminating the additional 20-30 minute anesthesia wait. Patients walk in, receive treatment, and leave within 45 minutes with zero visible signs of the procedure.
Is Sofwave FDA approved?
Sofwave received FDA 510(k) clearance in 2019 for non-invasive lifting of the eyebrow and submental tissue, plus improvement of facial lines and wrinkles. The device also holds CE marking for European markets and KFDA approval for use in Korean clinics. Clinical trials supporting the clearance demonstrated a 95% patient satisfaction rate.
What results can I expect from Sofwave?
Clinical studies show 90% of patients achieve measurable skin tightening at 12 weeks post-treatment. Initial improvement appears at 4 weeks as early collagen remodeling begins. Peak results occur at 3 months, with effects lasting 6-12 months from a single session. Annual maintenance sessions build cumulative improvement over successive years.
How does Sofwave compare to Ultherapy?
Sofwave operates at 1.5mm depth targeting mid-dermal collagen, while Ultherapy reaches 4.5mm to treat the deeper SMAS layer. Sofwave sessions take 30-45 minutes with pain rated 2-4 out of 10, compared to Ultherapy at 60-90 minutes with pain rated 5-7. The two technologies complement each other in multi-layer lifting protocols.
Is there any downtime after Sofwave?
Sofwave requires zero downtime, with 95% of patients returning to all normal activities immediately after treatment. Mild redness resolves within 30-60 minutes in most cases. No bruising, swelling, or tenderness occurs. Patients can apply makeup, exercise, and resume work the same day, making it one of the most convenient non-surgical lifting options available.

Book a Consultation

Free consultation. We respond within 24 hours.

Thank you! We will contact you within 24 hours.